Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
Egypt Heart J ; 74(1): 23, 2022 Apr 05.
Article in English | MEDLINE | ID: mdl-35380300

ABSTRACT

Myocarditis has been discovered to be a significant complication of coronavirus disease 2019 (COVID-19), a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. COVID-19 myocarditis seems to have distinct inflammatory characteristics, which make it unique to other viral etiologies. The incidence of COVID-19 myocarditis is still not clear as a wide range of figures have been quoted in the literature; however, it seems that the risk of developing myocarditis increases with more severe infection. Furthermore, the administration of the mRNA COVID-19 vaccine has been associated with the development of myocarditis, particularly after the second dose. COVID-19 myocarditis has a wide variety of presentations, ranging from dyspnea and chest pain to acute heart failure and possibly death. It is important to catch any cases of myocarditis, particularly those presenting with fulminant myocarditis which can be characterized by signs of heart failure and arrythmias. Initial work up for suspected myocarditis should include serial troponins and electrocardiograms. If myocardial damage is detected in these tests, further screening should be carried out. Cardiac magnetic resonance imagining and endomyocardial biopsy are the most useful tests for myocarditis. Treatment for COVID-19 myocarditis is still controversial; however, the use of intravenous immunoglobulins and corticosteroids in combination may be effective, particularly in cases of fulminant myocarditis. Overall, the incidence of COVID-19 myocarditis requires further research, while the use of intravenous immunoglobulins and corticosteroids in conjunction requires large randomized controlled trials to determine their efficacy.

2.
PLoS Negl Trop Dis ; 14(9): e0008700, 2020 09.
Article in English | MEDLINE | ID: mdl-32886678

ABSTRACT

Severe Acute Respiratory Syndrome Coronavirus 2 (COVID 19) has plagued the world with about 7,8 million confirmed cases and over 430,000 deaths as of June 13th, 2020. The knowledge, attitude, and practices (KAP) people hold towards this new disease could play a major role in the way they accept measures put in place to curb its spread and their willingness to seek and adhere to care. We sought to understand if: a) demographic variables of Cameroonian residents could influence KAP and symptomatology, and b) KAP could influence the risk of having COVID19.A cross-sectional KAP/symptomatology online survey was conducted between April 20 to May 20. All analyses were performed using SPSS version 23. Of all respondents (1006), 53.1% were female, 26.6% were students, 26.9% interacted face to face and 62.8% were residents in Yaoundé with a median age of 33. The overall high score was 84.19% for knowledge, 69% for attitude, and 60.8% for practice towards COVID 19. Age > 20 years was associated with a high knowledge of COVID 19. Women had lower practice scores compared to men (OR = 0.72; 95%CI 0.56-0.92). 41 respondents had ≥3 symptoms and only 9 (22.95%) of them had called 1510 (emergency number). There was no significant difference between KAP and symptomatology. The presence of ≥ 3 symptoms in 4% of respondents (with 56% of them having co-morbidities) supports the current trend in the number of confirmed cases (8681) in Cameroon. The continuous increase in the number of cases and the overall good KAP warrants further investigation to assess the effectiveness of the measures put in place to curb the spread of the disease. Sensitization is paramount to preclude negative health-seeking behaviors and encourage positive preventive and therapeutic practices, for fear of an increase in mortality.


Subject(s)
Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , Health Knowledge, Attitudes, Practice , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Primary Prevention/methods , Adult , Betacoronavirus , COVID-19 , Cameroon/epidemiology , Coronavirus Infections/diagnosis , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pneumonia, Viral/diagnosis , SARS-CoV-2 , Surveys and Questionnaires , Young Adult
3.
Pan Afr Med J ; 30: 158, 2018.
Article in English | MEDLINE | ID: mdl-30455787

ABSTRACT

INTRODUCTION: Lymph node tuberculosis remains widespread in Cameroon. Our goal was to compare the diagnostic agreement between the hematein-eosin coloration technique and the Ziehl-Neelsen technique. METHODS: This study is a retrospective and comparative study realized in the Yaounde University Teaching Hospital over a period of 5 years. We needed to specify the diagnostic agreement for tuberculosis, first inter observer and secondly between the standard and special colorations. The data we collected allowed us to determine the agreement rates observed and the kappa (k) coefficients with linear weighting. RESULTS: The 186 samples of the 1726 cases of tuberculosis of all locations represented a proportion of 10.78%. There were more male patients (65.05%) with a sex ratio (M:F) of 1.30. The average age was 24.21 ± 15.5 with the extremes from 5 to 68 years. The most represented age group was from 10 to 39 years. The two observers agreed in 93 cases using hematein eosin coloration (P0 = 83.87 %; k = 0.8109) and on 73 samples using the Ziehl-Neelsen coloration (P0 = 89.78 %; k = 0.7734). The two coloration techniques presented an agreement on 104 samples (P0 = 88.17 %; k = 0.8783). CONCLUSION: The routine choice of the hematein eosin coloration technique not paired with the coloration technique of Ziehl-Neelsen can effectively alleviate the program for fighting tuberculosis in an environment of limited resources.


Subject(s)
Coloring Agents/chemistry , Staining and Labeling/methods , Tuberculosis, Lymph Node/diagnosis , Adolescent , Adult , Aged , Cameroon/epidemiology , Child , Child, Preschool , Eosine Yellowish-(YS)/chemistry , Female , Hematoxylin/chemistry , Hospitals, University , Humans , Male , Middle Aged , Observer Variation , Retrospective Studies , Tuberculosis, Lymph Node/epidemiology , Tuberculosis, Lymph Node/pathology , Young Adult
4.
Pan Afr Med J ; 23: 66, 2016.
Article in English | MEDLINE | ID: mdl-27217890

ABSTRACT

INTRODUCTION: Tumors of salivary glands are rare. According to Johns and Goldsmith in 1989, their annual incidence is less than 1/100000 without noteworthy geographical gap. But other authors suggest that their distribution may vary according to the race and geographical location. In Cameroon, existing studies give incomplete data. Hence, we underwent this study in order to draw the general profile of salivary gland tumors in Cameroon. METHODS: A retrospective study was carried out on the period spanning from January 2000 to December 2010 (11 years). It was done in nine Pathology services of different hospitals in Yaoundé, Douala and Bamenda. We consulted the archive registers of those services, retaining any patient with salivary gland tumor, whatever the histological type or location. Information gathered was the year of diagnosis, the service, the age and sex, the site of the tumor (gland) the histological type and the benign/ malignant character. RESULTS: We recruited a total of 275 files. Women were 56% (154/275) and men 44% (121/275) of the sample. Fifty eight tumors were malignant (21.9%) while 217 were benign (78.1%). The overall mean age was 37.44 years, with extremes between 1 and 84 years. Pleomorphic adenoma (60.36%) was the most common benign tumor. Adenoid cystic carcinoma (31%), mucoepidermoid carcinoma (22.4%) and adenocarcinoma (19%) were the most common malignant tumors. Palate (66.7%), cheek (30%) and lips (3.3%) were the sites were the minor salivary glands were mostly involved. CONCLUSION: The differences with western world authors suggest a geographical variability of salivary gland tumors.


Subject(s)
Adenoma, Pleomorphic/epidemiology , Salivary Gland Neoplasms/epidemiology , Salivary Glands, Minor/pathology , Adenocarcinoma/epidemiology , Adenocarcinoma/pathology , Adenoma, Pleomorphic/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cameroon/epidemiology , Carcinoma, Adenoid Cystic/epidemiology , Carcinoma, Adenoid Cystic/pathology , Carcinoma, Mucoepidermoid/epidemiology , Carcinoma, Mucoepidermoid/pathology , Child , Child, Preschool , Female , Humans , Infant , Male , Middle Aged , Retrospective Studies , Salivary Gland Neoplasms/pathology , Young Adult
6.
Trop Doct ; 43(2): 54-6, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23796672

ABSTRACT

As far as we know, the accuracy of clinical judgment in diagnosing uterine cervical polyps has not been assessed in sub-Saharan Africa. Our objective was to discover the positive predictive value (PPV) of clinical judgment in the diagnosis of cervical polyps. This is a retrospective descriptive study of 192 patients, carried out by the Departments of Pathology and Gynaecology of the Yaoundé Gynaeco-Obstetric and Paediatric Hospital, Cameroon. The diagnosis of cervical polyp was confirmed by histopathology examination in 169 patients, giving a PPV rate of 88.0%. The PPV of clinical judgment in the diagnosis of cervical polyps is acceptable in our setting but the frequency of premalignant and malignant lesions encountered is too high (10.4%), even in the presence of a confirmed cervical polyp (8.9%). Even in areas where there are limited resources, we recommend a systematic histopathology examination of any clinically suspected cervical polyp.


Subject(s)
Polyps/diagnosis , Precancerous Conditions/diagnosis , Uterine Cervical Neoplasms/diagnosis , Adult , Cameroon , Child , Clinical Competence , Developing Countries , Female , Humans , Middle Aged , Polyps/pathology , Precancerous Conditions/pathology , Predictive Value of Tests , Retrospective Studies , Uterine Cervical Neoplasms/pathology
7.
Sante ; 18(1): 39-42, 2008.
Article in French | MEDLINE | ID: mdl-18684690

ABSTRACT

UNLABELLED: Tumours of the central nervous system (CNS) have not received much scientific attention in sub-Saharan Africa, especially in the central African zone. The aim of this study was to determine the relative frequency and different histologic types of CNS tumours seen in the neurosurgery units of Cameroon, a multiethnic country of central Africa. This retrospective study covers the decade from January 1996 through December 2006 in the three neurosurgery departments in Cameroon, at the Yaoundé General Hospital, the Yaoundé Central Hospital, and the Douala General Hospital. INCLUSION CRITERIA: All cases undergoing surgery in these units for a histologically-confirmed CNS tumour. There were 231 cases with complete files, accounting for 6.3% of total admissions in the various units. Patients' mean age was 46.3+/-20.6 years (range: 2 weeks to 74 years); the male/female ratio was 0.8. Paediatric patients made up 15.1% (n=35) of the population while adults comprised 84.9% (n=196). In all, 74.9% (n=173) of the tumours were intracranial and 25.1% (n=58) spinal; 167 (72.3%) were the primary site and 64 (27.7%) metastatic. The average age of patients with metastatic tumors was 42+/-18.5 years compared with 36.5+/-17.8 years for cases with primary tumors. Primary tumors were malignant in 34.2% (n=12) of the children and benign in 65.8% (n=23); among adults 22.7% (n=30) were malignant and 77.3% (n=102) benign. Meningiomas were the most frequent tumours in our series, with 56 (24.2%) cases, followed by 42 astrocytomas (18.1%). Most patients were younger than 55 years. In conclusion, CNS tumors occurred mainly before the age of 55 years and had a slight predilection for girls and women. Meningiomas were the most frequent tumors in adults while astrocytomas were more prevalent in children.


Subject(s)
Brain Neoplasms/epidemiology , Meningeal Neoplasms/epidemiology , Meningioma/epidemiology , Adolescent , Adult , Age Factors , Aged , Astrocytoma/epidemiology , Astrocytoma/pathology , Brain/pathology , Brain Neoplasms/pathology , Cameroon , Child , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Male , Meningeal Neoplasms/pathology , Meninges/pathology , Meningioma/pathology , Middle Aged , Neoplasm Staging
8.
Indian J Pharmacol ; 40(6): 266-70, 2008 Nov.
Article in English | MEDLINE | ID: mdl-21279183

ABSTRACT

AIM: The antioxidant effect of the methanol-methylene chloride extract of Terminalia glaucescens (Combretaceae) leaves was investigated in streptozotocin (STZ)-induced oxidative stress. METHODS: Oxidative stress was induced in mice by a daily dose of STZ (45 mg/kg body weight i.p.) for five days. From day one, before STZ injection, normal and diabetic-test mice received an oral dose of the extract (100 or 300 mg/kg b.w.) daily. Plasma metabolites, lipid peroxidation, and antioxidant enzymes in the liver were assessed and gain in body weight recorded. RESULTS: In normal mice the plant extract reduced food and water intake, blood glucose and LDL-C level and body weight gain, did not affect the lipid peroxidation in the liver, while the antioxidant enzyme activities seemed increased. Blood glucose was decreased (P < 0.05) in normal mice treated with 300 mg/kg extract. Diabetic mice pretreated with 100 mg/kg extract as diabetic control mice (DC) showed significant (P < 0.001) body weight loss, polyphagia and polydipsia, high plasma glucose level, decrease in the liver catalase, peroxidase, and superoxide dismutase activities, and increase in lipid peroxidation. The HDL-C level was lowered (P < 0.05) whereas LDL-C increased. In 300 mg/kg extract-pretreated diabetic mice the extract prevented body weight loss, increase of blood glucose level, lipid peroxidation in liver, food and water intake, and lowering of plasma HDL-C level and liver antioxidants; this extract prevented LDL-C level increase. CONCLUSION: These results indicate that T. glaucescens protects against STZ-induced oxidative stress and could thus explain its traditional use for diabetes and obesity treatment or management.

9.
Prog Urol ; 16(1): 36-9, 2006 Feb.
Article in French | MEDLINE | ID: mdl-16526537

ABSTRACT

OBJECTIVE: The authors review the epidemiological and histological features of urogenital tumours in Cameroon. METHODS: The authors conducted a retrospective study over a period of 18 years based on registries and clinical data of patients admitted to the Urology department of Yaoundé Central Hospital. RESULTS: A total of 2,371 urogenital tumours were identified, corresponding to 520 prostatic adenocarcinomas, 1,066 cases of benign prostatic hyperplasia, 41 testicular tumours (9 seminomatous tumours, 7 non-seminomatous tumours, 18 lymphomas, 4 benign papillomas and 2 rhabdomyosarcomas of the spermatic cord), 169 bladder tumours (25 transitional cell carcinomas, 70 squamous cell carcinomas, 67 adenocarcinomas, 2 lymphomas, 1 sarcoma and 1 benign papilloma), and 136 kidney tumours (20 Wilms tumours, 87 renal cell carcinomas, 6 transitional cell carcinomas, 16 lymphomas, 2 other malignant tumours and 5 adenomas). This survey also revealed 192 epididymal tumours, essentially cysts, 8 squamous cell carcinomas of the penis and 3 adenocarcinomas of the female urethra. Other tumours corresponded to condylomata acuminata. CONCLUSION: Urogenital tumours in Cameroon are dominated by prostatic tumours. The urogenital tract can also be the site of endemic Burkitt lymphoma in this country. These tumours are observed in young subjects.


Subject(s)
Urogenital Neoplasms/epidemiology , Urogenital Neoplasms/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Cameroon/epidemiology , Child , Female , Humans , Male , Middle Aged , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...